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ABSTRACT Bak is a pro-apoptotic protein widely distributed in different cell types that is associated with the mitochondrial
outer membrane, apparently through a C-terminal hydrophobic domain. We used infrared spectroscopy to study the
secondary structure of a synthetic peptide (3HN-
188ILNVLVVLGVVLLGQFVVRRFFKS211-COO) with the same sequence as
the C-terminal domain of Bak. The spectrum of this peptide in D2O buffer shows an amide I band with a maximum at 1636
cm1, which clearly indicates the predominance of an extended -structure in aqueous solvent. However, the peptide
incorporated in multilamellar dimyristoylphosphatidylcholine (DMPC) membranes shows a different amide I band spectrum,
with a maximum at 1658 cm1, indicating a predominantly -helical structure induced by its interaction with the membrane.
It was observed that through differential scanning calorimetry the transition of the phospholipid model membrane was
broadened in the presence of the peptide. Fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene (DPH) in fluid DMPC
vesicles showed that increasing concentrations of the peptide produced increased polarization values, which is compatible
with the peptide being inserted into the membrane. High concentrations of the peptide considerably broaden the phase
transition of DMPC multilamellar vesicles, and DPH polarization increased, especially at temperatures above the Tc transition
temperature of the pure phospholipid. The addition of peptide destabilized unilamellar vesicles and released encapsulated
carboxyfluorescein. These results indicate that this domain is able to insert itself into membranes, where it adopts an -helical
structure and considerably perturbs the physical properties of the membrane.
INTRODUCTION
The Bcl-2 family of proteins is known to be related to the
control of cell apoptosis. This family consists of the follow-
ing three different subfamilies: 1) anti-apoptotic members,
such as Bcl-2 and Bcl-xL, showing sequence homology in
Bcl-2 homology 1 (BH1), BH2, BH3 and, in most cases,
BH4 domains; 2) pro-apoptotic members, such as Bax and
Bak, which share homology with Bcl-2 at BH1, BH2, and
BH3; and 3) pro-apoptotic proteins, which only share ho-
mology with Bcl-2 in the BH3 domain, including Bid, Bik,
and Bim (Adams and Cory, 1998; Tsujimoto and Shimizu,
2000), and Fig. 1 shows a comparison of these different
proteins. When Bak (for Bcl-2 homologous antagonist/
killer) was cloned in two different ways (Farrow et al.,
1995; Chittenden et al., 1995b; Kiefer et al., 1995), it shared
25, 22, and 19% amino acid sequence identity with Bcl-2,
Bcl-xL, and Bax, respectively. In particular, Bak shares 53%
amino acid sequence with Bcl-2 in the BH1 and BH2
domains. In addition, Bak, like Bcl-2, contains a hydropho-
bic transmembrane domain at its carboxy terminus, indicat-
ing that it may exist as an integral membrane protein (Far-
row et al., 1995; Chittenden et al., 1995b; Kiefer et al.,
1995).
Heterodimerization between members of the Bcl-2 family
of proteins is a key event in the regulation of programmed
cell death. Mutational and structural analysis have indicated
that the BH1 and BH2 (and probably the BH3) domains are
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FIGURE 1 Representation of some of the Bcl-2 family members. Three
subfamilies are indicated: the Bcl-2 subfamily promotes cell survival,
whereas the Bax and BH3 subfamilies facilitate apoptosis. BH1 to BH4 are
conserved sequence motifs. TM is the transmembrane domain.
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essential for the dimerization of anti-apoptotic proteins with
pro-apoptotic proteins, and hence inhibit their pro-apoptotic
activity (Sattler et al., 1997). It has been proposed that the
BH3 domain of proteins like Bak and Bax may be sufficient
to prevent the normal ability of Bcl-2 to suppress apoptosis
(Boyd et al., 1995; Chittenden et al., 1995a; Zha et al., 1996;
Hunter and Parslow, 1996; Cosulich et al., 1997; Holinger et
al., 1999). It has also been observed that Bax and Bak may
interact with the permeability transition pore of mitochon-
dria to induce permeability transition with the loss of mem-
brane potential (), release of cytochrome c (Marzo et al.,
1998; Narita et al., 1998; Rosse´ et al., 1998; Shimizu et al.,
1999; Brenner et al., 2000) and subsequent activation of
caspase and apoptosis, the BH3 domain being essential for
such interactions. However, other pro-apoptotic proteins,
such as Bid and Bik, which only possess a BH3 domain,
produce apoptosis after the release of cytochrome c but do
not open the transition pore and so do not lead to the loss of
membrane potential (Shimizu and Tsujimoto, 2000). In
addition, truncated Bid may allosterically activate Bak to
produce intramembranous oligomerization, giving rise to a
pore for cytochrome c efflux (Wei et al., 2000). Note that in
the last mechanism, the pore is formed by Bid and Bak
proteins without the participation of the proteins involved in
the mitochondrial transition pore mentioned above, which
may explain why the transition pore is not involved in the
action of Bid/Bak, as mentioned above. The number of
possible ways in which apoptosis is produced may be fur-
ther increased if we take into account that Bak BH3 peptides
antagonize the Bcl-xL function and induce apoptosis by
means of a cytochrome c-independent activation of caspases
through caspase activating factors such as Apaf-1, a mech-
anism which is not associated to the loss of membrane
potential (Holinger et al., 1999).
Since the 3D structure of Bak is not known and because
this protein has not yet been purified, it is difficult to
understand the exact function of its domains. In particular,
it is difficult to identify the function of its hydrophobic
C-terminal domain, which, it has been suggested by analogy
with Bcl-2, may act as a membrane anchor (Farrow et al.,
1995; Chittenden et al., 1995b; Kiefer et al., 1995), meaning
that Bak exists as an integral membrane protein. Neverthe-
less, some experiments have been carried out with a trun-
cated form of Bak (Narita et al., 1998; Priault et al., 1999),
which has been seen to show pro-apoptotic activity inter-
acting with the membrane transition pore, and so this do-
main may serve as a mere anchor or targeting domain.
However, even if this is the case, it would be useful to
understand the interaction of Bak with membranes, because
the life or death of a cell may depend on the correct
targeting or anchoring of this protein.
In this paper we report our investigations into the sec-
ondary structure of the C-terminal domain of Bak, its inter-
action with model membranes, and its ability to disrupt their
barrier properties. It was found that this domain changes its
secondary structure when it interacts with the membrane
and may insert itself into the membrane, resulting in dis-
ruption. It also showed a strong potential to release encap-
sulated carboxyfluorescein, all of which points to the mem-
brane intrinsic character of this domain and to its ability to
form pores in the membrane.
MATERIALS AND METHODS
Materials
The synthetic peptide encompassing residues 188–211 of Bak (3HN-
188ILNVLVVLGVVLLGQFVVRRFFKS211-COO) was obtained from
Genemed (San Francisco, CA) and judged pure (95%) according to
HPLC and MALDITOF spectroscopy. 1,2-Dimyristoyl-sn-glycero-3-phos-
phatidylcholine (DMPC) and egg yolk phosphatidylcholine (EYPC) were
obtained from Avanti Polar Lipids (Alabaster, AL). Deuterium oxide
(D2O), 1,6-diphenyl-1,3,5-hexatriene (DPH), and 2,2,2-trifluoroethanol
(TFE) were purchased from Sigma Chemical Co. (Madrid, Spain). The
other solvents were from Merck (Darmstadt, Germany) and all other
reagents used were of analytical grade.
Transmission infrared spectroscopy
The infrared spectra were obtained by using a Bruker Vector 22 Fourier
transform infrared spectrometer equipped with a liquid nitrogen-cooled
MCT detector. Each spectrum was obtained by collecting 500 interfero-
grams with a nominal resolution of 4 cm1 and triangular apodization
using the sample shuttle accessory to average background spectra between
sample spectra over the same time period. The spectrometer was contin-
uously purged with dry air.
Samples were prepared from DMPC and Bak C-terminal domain stocks
dissolved in chloroform/methanol (1:1, v/v). Bak C-terminal domain (0.18
mol) with phospholipid, at a peptide/phospholipid molar ratio of 0.1, was
dried under a stream of N2, free of O2, and the last traces of solvents were
removed by evaporation under high vacuum for a further 3 h. Then, 200 l
of TFE were added and the sample was vortexed vigorously and dried as
described before. Samples were then hydrated in 100 l of D2O buffer (10
mM Hepes pD 7.4, 0.1 mM EDTA) and dispersed with vigorous vortex
mixing in the liquid-crystalline phase to form multilamellar vesicles
(MLV) for 1 h. Next, they were centrifuged at 13,200  g for 25 min. The
phospholipid phase at the top of the solution and the supernatant phase
were separated from the pellet and centrifuged again at 13,200  g for 25
min to obtain the highest degree of the phospholipid phase separation from
the supernatant. The phospholipid phase containing bound peptide (25 l)
was then transferred to a Specac 20710 cell equipped with CaF2 windows
and 25-m Teflon spacers (Specac, Kent, UK). Samples containing pure
peptide (without phospholipid) were dried from TFE as when mixed with
DMPC, and then hydrated in 25 l D2O buffer (10 mM Hepes, 0.1 mM
EDTA, pD 7.4), vortexed for 1 h, and transferred to a Specac 20710 cell,
as described above.
For temperature studies, samples were prepared as described before
with DMPC in the absence or presence of Bak (0.18 mol) at peptide/
phospholipid molar ratios of 0.1 and 0.05. They were then equilibrated at
the starting temperature for 30 min before acquisition and scanned between
5 and 49°C at 2°C intervals, with a 2-min delay between each consecutive
scan with a water bath interfaced to the spectrometer computer. Fourier
transform infrared (FTIR) spectra were obtained in a Philips PU9800
Fourier transform infrared spectrometer equipped with a deuterated tri-
glycine sulfate detector. Each spectrum was obtained by collecting 128
interferograms with a nominal resolution of 2 cm1 and triangular apo-
dization using the sample shuttle accessory to average background spectra
between sample spectra over the same time period.
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Spectral subtraction was performed interactively using the Spectra-Calc
program (Galactic Industries Corp., Salem, NH). The spectra were sub-
jected to deconvolution and second derivation using the same software.
Deconvolution was carried out using a  factor of 2 and a smoothing factor
of 0.4. Both deconvolution and derivation gave the number and position, as
well as an estimation of the bandwidth and intensity of the bands, making
up the amide I region. Data treatment and band decomposition of the
original amide I have been described previously (Arrondo et al., 1989,
1994). The fractional areas of bands in the amide I region were calculated
from the final fitted band areas.
Differential scanning calorimetry
Calorimetric measurements were performed in a Microcal MC-2 differen-
tial scanning calorimeter (Microcal Inc., Northampton, MA). All heating
scans were recorded at the same rate of 60°C min1 in the temperature
interval from 5 to 40°C. Before starting each scan, the samples were
equilibrated in the calorimetric cell for 15 min at 5°C. Appropriate amounts
of peptide and 1 mg of DMPC of the respective stock solutions in
chloroform/methanol (1:1 v/v) were dried under a stream of N2 and stored
under vacuum for 3 h. Then, 200 l of TFE were added, vigorously
vortexed, and dried as described before. The samples were then dispersed
in 0.1 mM EDTA, 10 mM Hepes, pH 7.4 buffer, hydrated in the liquid-
crystalline phase with vigorous vortex mixing to form MLV. Finally, a
reference-containing buffer and sample were placed into the calorimetric
cells for the measurement and the results were plotted as a function of the
peptide/lipid molar ratios. The MicroCal Origin softwares were used for
data acquisition and analysis. The exact lipid concentration was determined
according to the method of Bo¨ttcher et al. (1961) and values are normalized
according to the maximum enthalpy value obtained (6.96 kcal/mol).
Leakage of liposome contents
The leakage of liposome contents to the external medium was kinetically
monitored by measuring the release of the 5(6)-carboxyfluorescein (CF)
trapped inside the vesicles (Weinstein et al., 1977; Rex, 1996; Rex and
Schwarz, 1998; Simon and Gear, 1998).
To prepare large unilamellar vesicles (LUV) with a diameter of 100 nm,
we used the extrusion technique (Mayer et al., 1986). Ten mol of EYPC
and as tracer, [3H]-PC at a concentration of900 cpm/nmol in chloroform/
methanol (1:1) were dried under N2. The last traces of solvents were
removed by a further 3 h evaporation under high vacuum. Lipid was then
hydrated in a 50 mMMes pH 7.4, 50 mM K2SO4 buffer, containing 50 mM
purified CF (Rex, 1996) and dispersed by vortexing to form MLV. Sub-
sequently, the suspension was extruded 10 times through two stacked
100-nm pore size polycarbonate membranes (Millipore Inc., Bedford,
MA). The external dye was separated from the vesicles by gel filtration
over a Sephadex G-25 (1  20) column and eluted with a 50 mM Mes pH
7.4, 100 mM K2SO4 buffer. Vesicles were separated from larger particles
and untrapped CF eluting in the void volume of the column. To obtain a
homogeneous preparation, only the top fractions of the LUV elution peak
were collected and pooled. The total lipid content was quantified by liquid
scintillation counting after and before the extrusion and gel filtration. The
increase in CF fluorescence upon CF release was followed using a Flu-
oromax-3 from Jobin Yvon (Longjumeau, France) fluorescence spectro-
photometer with excitation at 490 nm (5-nm slit width) and emission
intensity was monitored at 520 nm (15-nm slit width). Measurements were
made in a thermostatted quartz cuvette with constant stirring at 25°C. A
small volume of vesicles was diluted in the buffer (50 mMMes pH 7.4, 100
mM K2SO4) to yield a total volume of 2 ml at a final phospholipid
concentration of 6 M. A baseline measurement of the fluorescence of
vesicles alone was made for 10 min. In our experimental conditions the
spontaneous leakage rate was 	5%. Then, Bak C-terminal peptide dis-
solved in TFE at 2 mg/ml or 0.5 mg/ml, or TFE vehicle was added.
Fluorescence was measured for 15 min, and then a small volume of
concentrated Triton X-100 (0.5% final, w/v) was added to determine the
maximum fluorescence attainable under conditions of totally solubilized
vesicles. The addition of 4 l TFE did not produce any substantial leakage.
The percentage of carboxyfluorescein released was determined by the
following equation: [(Ft
15 min  F0)/(Fmax  F0)]  100, where Ft
15min
is the maximum intensity 15 min after addition of peptide or TFE, F0 is the
intensity of vesicles alone at time 0, and Fmax is the intensity after addition
of Triton X-100.
Fluorescence polarization
Multilamellar vesicles of DMPC were prepared with appropriate amounts
of Bak C-terminal domain, using stock solutions in chloroform/methanol
(1:1, v/v) to give the required peptide/phospholipid molar ratios. Phospho-
lipid concentration was 0.02 mol. The fluorescent probe DPH was pre-
pared in tetrahydrofuran and added to the organic solvent solution before
drying to give a probe/lipid molar ratio of 1:500. Then samples were dried
and subsequently 100 l TFE were added and vortexed vigorously, dried
under a stream of nitrogen, and stored under vacuum for 3 h to totally
remove the organic solvent. Samples containing phospholipid and peptide
were then hydrated in 70 l filtered buffer (10 mM Hepes, 0.1 mM EDTA,
pD 7.4) and dispersed with vigorous vortex mixing in the liquid-crystalline
phase to form MLVs.
DPH fluorescence polarization was measured in a Hitachi F-4500
fluorescence spectrophotometer equipped with a polarization accessory.
Excitation and emission wavelengths were 350 and 452 nm, respectively,
with an excitation and emission slit width of 5 nm. Cuvette temperature
was monitored continuously by means of a thermistor probe.
Fluorescence polarization data were analyzed according to Hoffmann et
al. (1981). Essentially, a normalized polarization P(c) is defined for a
given peptide/lipid molar ratio (c) as: P(c)
 [P(c) P(0)]/[Pmax P(0)],
in which Pmax is the value of P(c) at very high peptide concentrations, P(c)
is the observed polarization value, and P(0) is the DPH polarization in the
absence of protein. Then, by fitting ln[1  P(c)] to a suitable straight line
it was found that P(c) 1 eMx, in whichM is a number corresponding
approximately to the maximum number of lipid chains that could fit around
an isolated intrinsic molecule in each half of the bilayer (Hoffmann et al.,
1981; Soloaga et al., 1999; Azpiazu et al., 1993), and x may be either x 

c for a transmembrane protein or x 
 c/(2  c) for a protein occupying
only one of the monolayers. Thus, by fitting the experimental results to a
theoretical P(c) versus (c) curve and ifM is independently known by other
procedures, for example DSC, transmembrane integral proteins can be
distinguished from non-transmembrane ones.
RESULTS
Secondary structure of the peptide as studied by
infrared spectroscopy
When Bak C-terminal domain peptide was prepared in D2O
buffer in the absence of phospholipids, the amide I band of
the infrared spectrum showed a maximum at 1636 cm1
(Fig. 2 A), a frequency which indicates the predominance of
-sheet in its secondary structure (Krimm and Bandekar,
1986; Susi and Byler, 1987; Arrondo et al., 1989, 1994;
Fabian et al., 1992; Gonza´lez et al., 1997; Zhang et al.,
1998). The amide I band was decomposed as shown in Fig.
2 B. The number and initial position of the component bands
were obtained from band-narrowed spectra by Fourier de-
convolution and derivation. The corresponding parameters,
band position, percentage area, and assignment of each
Structure of the C-Terminal Domain of Bak 235
Biophysical Journal 81(1) 233–243
spectral component are shown in Table 1. It can be seen
that the spectrum exhibited four component bands in the
1700–1600 cm1 region, although the band with the
lowest frequency (1602 cm1) cannot be attributed to
peptide bonds but rather to amino-acidic side chains. The
quantitative contribution of the other three bands to the
amide I contour was obtained by band curve-fitting of
the original spectrum. The component with the maximum
contribution (50%) was located at 1632 cm1, which
probably corresponds to intramolecular CAO vibrations
of peptidyl bonds within -pleated sheets (Krimm and
Bandekar, 1986; Susi and Byler, 1987; Arrondo et al.,
1989, 1993, 1994; Fabian et al., 1992; Arrondo and Gon˜i,
1999). The component at 1659 amounted to 45%, and can
be attributed to -helix (Arrondo et al., 1993; Arrondo
and Gon˜i, 1999). Finally, the component at 1682, corre-
sponding to only 5%, can be assigned to turns (Surewicz
et al., 1990; Fabian et al., 1993; Muga et al., 1993;
Gonza´lez et al., 1997; Zhang et al., 1998).
The infrared spectrum was quite different when Bak
C-terminal domain was resuspended in the presence of
multilamellar vesicles of DMPC, in which case the maxi-
mum of the amide I band was found at 1656 cm1, which
is indicative of a predominant -helical structure (Arrondo
et al., 1993; Arrondo and Gon˜i, 1999) (Fig. 2 C). The
1800–1700 region corresponds to the carbonyl ester band
coming mainly from the phospholipid acyl chains. Band
decomposition was carried out as described above for the
peptide in the absence of phospholipid, and it can be ob-
served that the main band (62%) was now centered at 1657
cm1, indicating the predominance of an -helical structure
(Arrondo et al., 1993; Arrondo and Gon˜i, 1999). The com-
ponent at 1637 cm1 (representing 28%) can be attributed
to -sheets (Krimm and Bandekar, 1986; Susi and Byler,
1987; Arrondo et al., 1989, 1993, 1994; Fabian et al., 1992;
Arrondo and Gon˜i, 1999). The high-frequency component
at 1678 cm1 can be assigned to turns (Surewicz et al.,
1990; Fabian et al., 1993; Muga et al., 1993; Gonza´lez et al.,
1997; Zhang et al., 1998) and corresponded to 10% of the
total area of the amide I band, which is assigned to peptidyl
bonds (i.e., excluding components from amino-acidic side
chains).
FIGURE 2 (A) FTIR spectrum of the Bak C-terminal domain in the
absence (solid line) and the presence (dashed line) of multilamellar vesi-
cles containing DMPC at a peptide/phospholipid molar ratio of 0.1 in D2O
buffer. (B) FTIR spectrum of the Bak C-terminal domain in the absence of
membranes (solid line) and in the presence (C) of multilamellar vesicles
containing DMPC at a peptide/phospholipid molar ratio of 0.1 in D2O
buffer (solid line) with the fitted component bands (dashed line). The
position of the individual bands was obtained from the resolution-enhanced
spectrum. The parameters corresponding to the component bands are
reflected in Table 1. The dotted line represents the curve-fitted spectrum.
TABLE 1 FTIR parameters of the amide I band components
of the Bak C-terminal domain in the absence or presence of
multilamellar vesicles containing DMPC in 10 mM Hepes and
0.1 mM EDTA-D2O buffer (pD 7.4)









1682 Turns 5 1678 Turns 10
1659 -Helix 45 1657 -Helix 62
1632 -Pleated sheet 50 1638 -Pleated sheet 28
*Peak position of the amide I band components.
†Percentage area of the band components of amide I. The areas corre-
sponding to side chain contributions located at 1615-1600 cm1 have not
been considered.
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The effect of Bak C-terminal domain on the
stretching vibration of the CAO ester of DMPC
The thermotropic phase behavior of pure DMPC and in the
presence of Bak C-terminal domain was also examined by
monitoring the temperature dependence of the stretching
vibration peak arising from the CAO ester of the phospho-
lipid, which provides information on the state of the lipid-
water interface of the membrane. In Fig. 3 the deconvolu-
tions of the spectra are presented. The CAO peak from the
pure DMPC sample (Fig. 3 A) at 9°C, i.e., below the phase
transition temperature, showed a broad band which can be
deconvolved into two components, one at 1742 cm1 and
the other at 1731 cm1. The frequencies of these two
components were not affected by temperature and remained
the same at 47°C, i.e., above the phase transition tempera-
ture, but their relative intensities changed, as has been
reported for other phospholipids (Mantsch and McElhaney,
1991). Whereas at temperatures below the phase transition,
the 1742 cm1 component was more intense than the 1731
cm1 component, the contrary was observed at tempera-
tures above the phase transition. As has been shown by a
number of authors (Blume et al., 1988; Hu¨bner and
Mantsch, 1991; Mantsch and McElhaney, 1991; Lewis et
al., 1994), the component occurring at the highest frequency
can be attributed to unhydrated CAO groups, whereas the
other component is assigned to hydrated CAO groups.
Therefore, a higher proportion of CAO groups are hydrated
at temperatures above the gel-to-liquid-crystalline phase
transition temperature than below, as has been shown in the
case of other diester phospholipids (Mantsch and McEl-
haney, 1991). The incorporation of peptide to give a Bak
C-terminal domain/DMPC molar ratio of 0.1 (Fig. 3 B)
resulted in a clearly narrower CAO vibration peak at 9°C.
The half-bandwidth of 35.7 cm1 obtained for pure DMPC
at 9°C fell to 32.6 cm1 at the same temperature in the
presence of the peptide. Similarly, at 48°C, the band corre-
sponding to pure DMPC has a width of 38.5 cm1, com-
pared with 34.6 cm1 in the presence of the C-terminal
domain of Bak. These changes in width, and those described
above for the frequency of the peak maximum, can be
explained by a quantitative increase in the importance of the
subcomponent with the highest frequency, which is attrib-
uted to unhydrated CAO groups. It seems, then, that the
presence of the peptide induces a certain increase in the
proportion of unhydrated carbonyl ester groups of the phos-
pholipid molecules.
Differential scanning microcalorimetry
Pure DMPC multilamellar vesicles and vesicles containing
different concentrations of Bak C-terminal domain peptide
were studied by DSC with the aim of obtaining information
on the way in which this peptide interacts with the mem-
brane. Fig. 4 A shows that the presence of a low peptide
content, as in a 0.01 peptide/DMPC molar ratio, already
occasioned the disappearance of the pretransition and the
widening of the main transition so that the onset took place
at 20.4°C instead of 23°C, which is the onset temperature
of the main transition for pure DMPC. This peak was
centered at 22.5°C. At 0.02 molar ratio the transition was
further widened and the onset was located at 18.5°C, and the
transition peak was clearly asymmetric with the maximum
of the peak centered at 21.2°C. At 0.05 molar ratio the
transition peak was quite wide with the onset at 11.1°C.
At 0.1 molar ratio the transition was very smeared and the
onset was at 12.5°C. The pattern of variation of the transi-
tion peak with increasing concentrations of peptide indi-
cated a strong effect on the transition, which became in-
creasingly less cooperative and wider and with a lower H,
which decreased linearly with peptide/DMPC molar ratio
(Fig. 4 B). Extrapolation of this plot gives us the point at
which H becomes zero. This is usually interpreted as the
average number of phospholipid molecules that are pre-
vented from undergoing the thermotropic transition per
peptide molecule. In our case, the corresponding data are
about five phospholipid molecules per one peptide mole-
cule.
Fluorescence probe polarization spectroscopy
To obtain more information on the interaction of Bak C-
terminal domain peptide with membranes, experiments
FIGURE 3 FTIR spectra of DMPC in the absence (A) and in the pres-
ence (B) of the Bak C-terminal domain at a peptide/DMPC molar ratio of
0.1. Original (solid line) and its deconvolution (dashed line) spectra are
represented at different temperatures as indicated, showing the carbonyl
stretching region. The maxima of peaks or subcomponents are given.
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based on changes in fluorescence polarization of the probe
DPH were carried out.
DPH fluorescence polarization was first studied at differ-
ent temperatures to monitor the influence of the Bak C-
terminal domain peptide on the phase transition of DMPC
vesicles in which it was incorporated (Fig. 5). The presence
of the peptide at a peptide/DMPC molar ratio of 0.05
resulted in a broadening of the phase transition of the pure
phospholipid, this effect being clear from the increased
degree of polarization above of the phase transition temper-
ature. This pattern was also observed for a sample contain-
ing a peptide/DMPC molar ratio of 0.1, the phase transition
being further broadened and polarization values increasing
above the phase transition, which indicated a considerable
increase in apparent membrane microviscosity in the pres-
ence of the peptide.
The phase transition for DPH polarization was also stud-
ied at a fixed temperature of 30°C so that the DMPC
membrane was in a fluid state. Fig. 6 shows that increasing
concentrations of the peptide produced increasing polariza-
tion values, which is in agreement with the effects reported
for other intrinsic molecules, such as Ca2-ATPase
(Go´mez-Ferna´ndez et al., 1980), cholesterol and cyto-
chrome c oxidase (Hoffmann et al., 1981), bacteriorhodop-
sin (Alonso et al., 1982), myelin apolipoprotein (Gon˜i et al.,
1988), Pf-1 viral protein (Azpiazu et al., 1993), -hemoly-
sin (Soloaga et al., 1999) and, more recently, with the
C-terminal domain of Bcl-2 (Martı´nez-Senac et al., 2000).
The experimental data were fitted to exponential lines ac-
cording to the model of Hoffmann et al. (1981). The lines in
Fig. 6 correspond to the P(c) 
 1  eMx equation for the
M range indicated, assuming x
 c (transmembrane protein)
FIGURE 4 (A) DSC heating thermograms of aqueous dispersions of DMPC (MLV) with the Bak C-terminal domain peptide obtained at different
peptide/DMPC molar ratios as indicated. (B) Enthalpy change associated with the main gel-fluid phase transition of DMPC in phospholipid-peptide
mixtures, as a function of peptide/lipid molar ratio shown in the DSC thermograms of this figure. The value of peptide/lipid molar ratio at which the phase
transition enthalpy reaches zero was extrapolated to a value of 0.22, corresponding to a lipid/peptide molar ratio of 5:1.
FIGURE 5 Fluorescence polarization as a function of temperature of
DPH in DMPC (MLV) (10 M) (probe/lipid molar ratio of 1:500) in the
absence (F) or in the presence of the Bak C-terminal domain at 0.05 (E)
and 0.1 () peptide/DMPC molar ratios. Experiments were carried out at
constant stirring. Two independent experiments were carried out with 25
determinations for each experiment.
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or x 
 c/(2  c) (protein occupying only one of the
monolayers) (see Materials and Methods). The x 
 c as-
sumption (Fig. 6 A) fits the data to a curve obtaining an M
range between 5 and 9. Using the x 
 c/(2  c) assumption
(Fig. 6 B), an M range between 9 and 16 has been obtained.
Since the valueM 5 was found from the DSC data, it may
be concluded that the x 
 c assumption (transmembrane
protein with M range 
 5–9) is the best fit to experimental
data and hence a number of phospholipid molecules close to
5 are perturbed by each C-terminal domain peptide of Bak.
Leakage of CF induced by Bak C-terminal
domain peptide
To further assess the insertion of the peptide in membranes,
the release of encapsulated CF trapped inside LUVs was
monitored at increasing concentrations of peptide. EYPC
vesicles at 25°C, i.e., in the fluid state, were used in these
experiments rather than the DMPC used in the other exper-
iments reported in this work, because DMPC vesicles rap-
idly release the dye even in the absence of peptide, as has
been reported by others (Bramhall et al., 1987). Fig. 7
shows how the peptide released up to 95% of the probe
within 15 min of the addition of the peptide at a peptide/
lipid molar ratio of 0.04. This result indicates that the
peptide may disrupt the barrier properties of the phospho-
lipid bilayer by inserting itself into this membrane, thus
forming very conductive pores.
DISCUSSION
In this paper we have used a number of physical tech-
niques to study the structure and interaction of the C-
terminal domain of Bak with model membranes, and the
first conclusion that can be reached from the results
obtained is that this peptide is able to incorporate into
phospholipid vesicles as an integral molecule. It should
be considered that the C-terminal domain of Bak is
considerably hydrophobic and the phospholipid used to
prepare the model membranes is phosphatidylcholine.
This phospholipid is zwitterionic and very well known to
lack the capacity to attract proteins from outside the
membrane (Chapman, 1993; Herna´ndez-Caselles et al.,
1993). By this reason if an interaction is detected be-
FIGURE 6 Normalized polarization P(c) of DPH fluorescence in DMPC (MLV) (10 M) (probe/lipid molar ratio of 1:500) with the Bak C-terminal
domain at increasing molar fractions (c). The experimental data were fitted to exponential lines that correspond to the P(c) 
 1  eMx equation, where
M is a number corresponding approximately to the maximum number of lipid chains that could fit around an isolated intrinsic molecule in each half of the
bilayer, assuming (A) x
 c (transmembrane model) with anM range between 5 and 9 and (B) x
 c/(2 c) (peptide occupying only one of the monolayers)
with an M range between 9 and 16. Experiments were carried out at 30°C with constant stirring. Measurements were made in two independent experiments
with 25 determinations for each experiment.
FIGURE 7 Leakage of carboxyfluorescein from EYPC (LUV) induced
by the Bak C-terminal domain. The percentage of carboxyfluorescein
released after 15 min of incubation with increasing concentrations of
peptide was plotted as a function of the peptide/lipid molar ratio (c); 100%
of leakage was established by lysing LUV with Triton X-100 (0.5%, w/v).
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tween this peptide and a phosphatidylcholine membrane
this interaction is most probably of hydrophobic type.
The infrared study clearly shows that the C-terminal
domain of Bak significantly changes its secondary structure
in the presence of phospholipid vesicles. Whereas the ex-
tended -structure was predominant in D2O buffer solution,
the -helical structure became the most important (62%),
when the peptide was resuspended with DMPC vesicles.
There are many known examples of the folding of mem-
brane-active peptides induced by lipid membranes (Kaiser
and Kezdy, 1984, 1987; Schwyzer, 1995; White and Wim-
ley, 1998; Silvestro and Axelsen, 2000). Recently, it has
been shown that some peptides do not require anionic lipids
to fold or to exhibit permeabilizing membrane activity, e.g.,
magainin and cecropin A (Wieprecht et al., 1999) and the
C-terminal domain of Bcl-2 (Martı´nez-Senac et al., 2000). It
appears, then, that the C-terminal domain of Bak also folds
and permeabilizes membranes without the need of anionic
phospholipids. In this case, hydrophobic interactions must
be important, probably due to the clearly hydrophobic na-
ture of this peptide, which favors its insertion into the
membrane. It is interesting to underline, in this context, the
remarkable hydrophobicity of this peptide compared with
the C-terminal domain of Bcl-2, the former being 71%
composed of hydrophobic amino acids and the second 55%.
Despite this, when the two sequences are aligned they share
78% homology and 28% identity, suggesting that these
peptides probably form a special group of signaling-local-
ization peptides belonging to apoptotic-related proteins.
Note that whereas hydrophobic peptides will adopt trans-
membrane dispositions (Azpiazu et al., 1993; Arkin et al.,
1995; Zhang et al., 1995) other peptides with amphipathic
structure have been reported to remain bound to the surface
(Ishiguro et al., 1993; Gazit et al., 1996; Ghosh et al., 1998;
Oren et al., 1999; Hong et al., 1999; Ben-Efraim et al.,
1999).
It was deduced from DSC that the peptide broadens the
phase transition of DMPC without significantly shifting the
center of this transition. Although when hydrophobic mis-
matches exist the phase transition may be considerably
shifted, the shift may be not so important when the mis-
match with the fatty acyl chains of the phospholipids is not
large (Mouritsen and Bloom, 1993; Chapman et al., 1979;
Soloaga et al., 1999). Since we are using DMPC and a
peptide with a hydrophobic stretch sufficiently long to span
the membrane, an important hydrophobic mismatch should
not be expected. In addition, the study of the CAO stretch-
ing indicated that the peptide modified the lipid-water in-
terface as it increased the proportion of dehydrated ester
carbonyls of the phospholipid.
It was also observed that increasing peptide concentra-
tions increased the polarization of the fluorescent probe
DPH. Steady-state fluorescence polarization provides a
time-averaged indication of the mobility of a fluorophore.
DPH is a hydrophobic fluorescent molecule that, when
incorporated into a lipid bilayer, is located in the hydropho-
bic region. In pure lipid bilayers DPH is freely mobile and
its fluorescence is minimally polarized. The presence of
intrinsic membrane proteins may restrict the mobility of the
probe, therefore increasing its polarization. The polarization
of diphenylhexatriene fluorescence has been studied to un-
derstand protein-induced changes in lipid dynamics
(Go´mez-Ferna´ndez et al., 1980; Azpiazu et al., 1993; So-
loaga et al., 1999). It is deduced from the increase in
polarization caused by the C-terminal domain of Bak that its
presence increased the apparent order of the membrane by
restricting the mobility of the probe molecules. This effect
is the same as that found for many intrinsic molecules
(Go´mez-Ferna´ndez et al., 1980; Hoffmann et al., 1981;
Azpiazu et al., 1993; Soloaga et al., 1999; Martı´nez-Senac
et al., 2000) and is compatible with the notion that this
peptide becomes a membrane integral molecule in the pres-
ence of phospholipid vesicles. In addition to this, quantita-
tive results arising from differential scanning calorimetry
and fluorescence polarization studies provide strong support
to the hypothesis of the transmembrane character of the
C-terminal domain of Bak. In fact, both techniques can
provide a figure of the average number of lipids that are
perturbed by the presence of the peptide, so that they appear
to be removed from the gel-fluid phospholipid transition. In
our case, and given that phosphatidylcholine was the only
type of phospholipid present in the membrane and the
results obtained with the other biophysical techniques, the
most likely explanation is that the peptide is incorporated
into the membrane in a transmembrane disposition. How-
ever, in some cases of interaction of peptides with model
membranes a variation in polarization is observed where the
interaction is basically electrostatic, as in the case of poly-
lysine and phosphatidylglycerol (Houbre et al., 1988).
A study of the phase transition of DMPC both in the
absence and in the presence of peptide by steady-state
fluorescence polarization of DPH confirmed the results de-
tected by DSC, namely that the peptide produced a broad-
ening of the phase transition without essentially modifying
the temperature at which the center of the transition was
taking place. In addition, it was found that the peptide
increased the polarization values of DPH mainly at temper-
atures above the phase transition. By combining data ob-
tained from DSC and fluorescence polarization of DPH we
found that the experimental data are better fitted to a model
in which the peptide occupies a transmembrane disposition.
These observations again support the membrane intrinsic
nature of the peptide.
Insertion of the peptide into the model membranes was
also confirmed by experiments that showed carboxyfluores-
cein leakage from phospholipid vesicles induced by the
C-terminal domain of Bak, which indicates that the peptide
penetrates the lipid hydrophobic core, breaking the barrier
properties of the membrane, although it is not clear whether
this effect is related to the physiological effect of Bak on the
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biological membranes. This concentration-dependent per-
meabilization was probably due to a pore formed by the
aggregation of peptide molecules, similar to what we pre-
viously suggested for the Bcl-2 C-terminal domain (Mar-
tı´nez-Senac et al., 2000).
The role of the C-terminal domain of Bak in the function
of this protein is far from clear at the present moment. It
might be that this domain will act simply as an anchor or
targeting signal, but no experiments have been carried out
so far to adequately test this possibility, as only truncated
forms of the protein lacking this domain have been used
(Narita et al., 1998; Priault et al., 1999). These experiments
indicated that the protein has the capacity of opening the
permeability transition pore of mitochondria. Nevertheless,
given the tendency of these proteins to oligomerize with
other members of the family, they could be located in
membranes even if they lacked the anchor domain. In ad-
dition, the information described above does not preclude
that this domain may contribute to the pro-apoptotic activity
of Bak, whether it forms a pore itself (together with Bid), or
even if the activity of full-Bak, which has been very poorly
studied, is different from that of truncated Bak. It has been
proposed that Bax, which belongs to the same subfamily as
Bak, forms channels that render the membrane permeable
for cytochrome c (Basan˜ez et al., 1999; Nouraini et al.,
2000), that its insertion and oligomerization in the mem-
brane is promoted by Bid (Eskes et al., 2000), and that the
C-terminal hydrophobic domain is a key element for the
insertion of the protein in outer mitochondrial membranes in
vivo (Goping et al., 1998; Nechushtan et al., 1999).
In summary, we have found that the peptide which imi-
tates the C-terminal domain of Bak interacts with model
phospholipid membranes, altering their physical properties
and making them leaky to carboxyfluorescein (hence indi-
cating the insertion of Bak into the membrane). At the same
time, the peptide is folded by its interaction with the mem-
brane to adopt a secondary structure in which -helix is
predominant. These results confirm that this domain may
act as an anchor for the Bak protein in the membrane, and
also that Bak may eventually help to create a pore through
the outer mitochondrial membrane.
This work was supported by Grant PB98-0389 from Direccio´n General de
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